GET THE APP

Журнал рассеянного склероза

ISSN - 2376-0389

Объем 9, Проблема 12 (2022)

исследовательская статья

Two-year Assessment of the Efficacy and Safety of Ocrelizumab in Switching Patients from Other Disease Modifying Therapies

Terzi Murat, Boz Cavit, Demir Caner Feyzi, Cilingir Vedat, Helvaci Elif Merve